Literature DB >> 8507795

Biodegradation and brain tissue reaction to poly(D,L-lactide-co-glycolide) microspheres.

P Menei1, V Daniel, C Montero-Menei, M Brouillard, A Pouplard-Barthelaix, J P Benoit.   

Abstract

The therapeutic application of neuroactive molecules in neuroscience is limited, due to the problems posed by the administration of these drugs (peripheral metabolism, systemic effect and passage of the blood-brain barrier). One solution is the implantation in the brain of biodegradable polymer devices with controlled release of a neuroactive drug. The biodegradation and tissue reaction of the copolymer poly(D,L-lactide-co-glycolide) microspheres prepared by the solvent evaporation method, radiosterilized and stereotactically implanted in the rat brain were studied by routine staining, immunohistochemistry and transmission electronic microscopy. The brain tissue reaction observed was a non-specific astrocytic proliferation and a macrophagous-microglial cell reaction, typically found following damage to the central nervous system. Some foreign-body giant cells were observed and the inflammatory and macrophagous reaction decreased dramatically after 1 month and almost ended after 2 months when the microspheres were totally biodegraded. The copolymer poly(D,L-lactide-co-glycolide) microspheres may be considered biocompatible to the brain tissue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8507795     DOI: 10.1016/0142-9612(93)90151-q

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  24 in total

Review 1.  Drug transport to brain with targeted nanoparticles.

Authors:  Jean-Christophe Olivier
Journal:  NeuroRx       Date:  2005-01

Review 2.  Inductive tissue engineering with protein and DNA-releasing scaffolds.

Authors:  David M Salvay; Lonnie D Shea
Journal:  Mol Biosyst       Date:  2005-11-25

3.  Towards more realistic in vitro release measurement techniques for biodegradable microparticles.

Authors:  D Klose; N Azaroual; F Siepmann; G Vermeersch; J Siepmann
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

Review 4.  Nanocarriers for tracking and treating diseases.

Authors:  Sean Marrache; Rakesh Kumar Pathak; Kasey L Darley; Joshua H Choi; Dhillon Zaver; Nagesh Kolishetti; Shanta Dhar
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

5.  BCNU/PLGA microspheres: a promising strategy for the treatment of gliomas in mice.

Authors:  Tongming Zhu; Yiwen Shen; Qisheng Tang; Luping Chen; Huasong Gao; Jianhong Zhu
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

Review 6.  Biomaterials for the central nervous system.

Authors:  Yinghui Zhong; Ravi V Bellamkonda
Journal:  J R Soc Interface       Date:  2008-09-06       Impact factor: 4.118

7.  In vitro and in vivo degradation of poly(D, L-lactide-co-glycolide)/amorphous calcium phosphate copolymer coated on metal stents.

Authors:  Xiaodong Ma; Shizu Oyamada; Tim Wu; Michael P Robich; Hao Wu; Xingwei Wang; Bryan Buchholz; Stephen McCarthy; Cesario F Bianchi; Frank W Sellke; Roger Laham
Journal:  J Biomed Mater Res A       Date:  2011-01-25       Impact factor: 4.396

8.  Spatiotemporal presentation of exogenous SDF-1 with PLGA nanoparticles modulates SDF-1/CXCR4 signaling axis in the rodent cortex.

Authors:  D Dutta; K Hickey; M Salifu; C Fauer; C Willingham; S E Stabenfeldt
Journal:  Biomater Sci       Date:  2017-07-25       Impact factor: 6.843

9.  Effects of solvent used for fabrication on drug loading and release kinetics of electrosprayed temozolomide-loaded PLGA microparticles for the treatment of glioblastoma.

Authors:  Daniel A Rodriguez de Anda; Nareg Ohannesian; Karen S Martirosyan; Sue Anne Chew
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2019-02-15       Impact factor: 3.368

10.  5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy.

Authors:  Yuting Lin; Yan Li; Chui Ping Ooi
Journal:  J Mater Sci Mater Med       Date:  2012-07-29       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.